92 related articles for article (PubMed ID: 12060184)
1. Implications of lipid biology for the pathogenesis of schizophrenia.
Berger GE; Wood SJ; Pantelis C; Velakoulis D; Wellard RM; McGorry PD
Aust N Z J Psychiatry; 2002 Jun; 36(3):355-66. PubMed ID: 12060184
[TBL] [Abstract][Full Text] [Related]
2. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
Reddy R; Keshavan MS
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
[TBL] [Abstract][Full Text] [Related]
3. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.
Fenton WS; Hibbeln J; Knable M
Biol Psychiatry; 2000 Jan; 47(1):8-21. PubMed ID: 10650444
[TBL] [Abstract][Full Text] [Related]
4. [Lipid abnormalities in schizophrenia--current knowledge].
Michalak G
Psychiatr Pol; 2003; 37(6):965-76. PubMed ID: 14727369
[TBL] [Abstract][Full Text] [Related]
5. Bioactive lipids in schizophrenia.
Berger GE; Smesny S; Amminger GP
Int Rev Psychiatry; 2006 Apr; 18(2):85-98. PubMed ID: 16777663
[TBL] [Abstract][Full Text] [Related]
6. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
7. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
9. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
[TBL] [Abstract][Full Text] [Related]
10. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.
Arvindakshan M; Sitasawad S; Debsikdar V; Ghate M; Evans D; Horrobin DF; Bennett C; Ranjekar PK; Mahadik SP
Biol Psychiatry; 2003 Jan; 53(1):56-64. PubMed ID: 12513945
[TBL] [Abstract][Full Text] [Related]
11. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
[TBL] [Abstract][Full Text] [Related]
12. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
Puri BK
Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
[TBL] [Abstract][Full Text] [Related]
13. Essential fatty acids and the brain.
Haag M
Can J Psychiatry; 2003 Apr; 48(3):195-203. PubMed ID: 12728744
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study.
Keshavan MS; Stanley JA; Montrose DM; Minshew NJ; Pettegrew JW
Mol Psychiatry; 2003 Mar; 8(3):316-23, 251. PubMed ID: 12660804
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of intracellular lipid metabolism by the preparation of omega-3 phospholipids from marine organisms in deficiency of essential fatty acids in rats].
Cherniavs'kyĭ PV; Datsenko ZM; Moiseieva LH; Kanivets' NV; Kozulina OP; Boroda AM; Abakumova OS
Ukr Biokhim Zh (1999); 2006; 78(5):101-13. PubMed ID: 17290788
[TBL] [Abstract][Full Text] [Related]
17. [Diseases of phospholipid metabolism as possible pathogenetic factors in schizophrenia. Current findings and critical evaluation].
Smesny S; Volz HP; Riehemann S; Sauer H
Fortschr Neurol Psychiatr; 2000 Jul; 68(7):301-12. PubMed ID: 10945156
[TBL] [Abstract][Full Text] [Related]
18. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
du Bois TM; Deng C; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):878-88. PubMed ID: 16005134
[TBL] [Abstract][Full Text] [Related]
19. [Biology of essential fatty acids (EFA)].
Dobryniewski J; Szajda SD; Waszkiewicz N; Zwierz K
Przegl Lek; 2007; 64(2):91-9. PubMed ID: 17892040
[TBL] [Abstract][Full Text] [Related]
20. Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia.
Klemm S; Rzanny R; Riehemann S; Volz HP; Schmidt B; Gerhard UJ; Filz C; Schönberg A; Mentzel HJ; Kaiser WA; Blanz B
Am J Psychiatry; 2001 Jun; 158(6):958-60. PubMed ID: 11384908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
